7-[1H-indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors:: Design, synthesis, and biological activity

被引：22

作者：

Hughes, Terry V. ^{[1
]}

Emanuel, Stuart L. ^{[1
]}

O'Grady, Harold R. ^{[1
]}

Connolly, Peter J. ^{[1
]}

Rugg, Catherine ^{[1
]}

Fuentes-Pesquera, Angel R. ^{[1
]}

Karnachi, Prabha ^{[1
]}

Alexander, Richard ^{[1
]}

Middleton, Steven A. ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ 08869 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 18期

关键词：

cancer; Aurora-A; Aurora-B; Aurora-C; kinase; vascular endothelial growth factor receptor 2; VEGF-R2; kinase inhibition; isoindolinone; 2,3-dihydro-isoindol-1-ones;

D O I：

10.1016/j.bmcl.2008.07.090

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of 7-[1H-indol-2-yl]-2,3-dihydro-isoindol-1-ones designed to be inhibitors of VEGF-R2 kinase was synthesized and found to potently inhibit VEGF-R2 and Aurora-A kinases. The structure-based design, synthesis, and initial SAR of the series are discussed. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：5130 / 5133

页数：4

共 50 条

[31] Identification of substituted 3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as growth factor receptor inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rβ tyrosine kinases
Sun, L
Tran, N
Liang, CX
Hubbard, S
Tang, F
Lipson, K
Schreck, R
Zhou, Y
McMahon, G
Tang, C
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) : 2655 - 2663
[32] Synthesis and transformations of ethyl (Z)-2-(2,3-dihydro-1,3-dioxo-1H-isoindol-2-yl)-3-(dimethylamino)propenoate
Bevk D.
Kmetic M.
Recnik S.
Svete J.
Golic L.
Golobic A.
Stanovnik B.
Chemistry of Heterocyclic Compounds, 2001, 37 (12) : 1498 - 1510
[33] Synthesis and Antimicrobial Activity of (E)-2-[(1-Substituted Phenyl-1H-1,2,3-triazol-4-yl)methylene]-2,3-dihydro-1H-inden-1-ones
Swamy, M. K.
Swapna, M.
Sandeep, T.
Rao, P. Venkateswar
RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2019, 89 (09) : 1884 - 1886
[34] Synthesis and Antimicrobial Activity of (E)-2-[(1-Substituted Phenyl-1H-1,2,3-triazol-4-yl)methylene]-2,3-dihydro-1H-inden-1-ones
M. K. Swamy
M. Swapna
T. Sandeep
P. Venkateswar Rao
Russian Journal of General Chemistry, 2019, 89 : 1884 - 1886
[35] Synthesis and Biological Activity of New 2,3-dihydro-1H-cyclopenta[b]quinoline Derivatives as Acetylcholinesterase Inhibitors
Szymanski, Pawel
Markowicz, Magdalena
Bajda, Marek
Malawska, Barbara
Mikiciuk-Olasik, Elzbieta
LETTERS IN DRUG DESIGN & DISCOVERY, 2012, 9 (07) : 645 - 654
[36] The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones:: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)
Jagtap, PG
Southan, GJ
Baloglu, E
Ram, S
Mabley, JG
Marton, A
Salzman, A
Szabó, C
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 81 - 85
[37] DUAL SRC/IGF-1R INHIBITORS BASED ON 2-(1H-INDOL-3-YL)-2-OXOACETOHYDRAZIDE SCAFFOLD
Schmidt, Stefanie
Totzke, Frank
Schaechtele, Christoph
Kubbutat, Michael H. G.
Lemcke, Thomas
Preu, Lutz
Kunick, Conrad
DRUGS OF THE FUTURE, 2009, 34 : 177 - 177
[38] Molecular Docking Studies, Antiproliferative Evaluation, and Synthesis of 7-(1H-Indol-3-yl)pyrido[2,3-d]pyrimidine Derivatives
M. A. Radwan
O. Al Rugaie
W. Al Abdulmonem
H. Awad
E. Zayed
Russian Journal of Bioorganic Chemistry, 2022, 48 : 809 - 820
[39] Molecular Docking Studies, Antiproliferative Evaluation, and Synthesis of 7-(1H-Indol-3-yl)pyrido[2,3-d]pyrimidine Derivatives
Radwan, M. A.
Al Rugaie, O.
Al Abdulmonem, W.
Awad, H.
Zayed, E.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2022, 48 (04) : 809 - 820
[40] Design, synthesis, QSAR and biological screening of novel 2-(2, 3-dioxo-2, 3-dihydro-1H-indol-1-yl)-N-phenylacetamide as cytotoxic agents
Shah, Ravi J.
Modi, Neha R.
Patel, Manish J.
Chauhan, Bhupendrasinh F.
Patel, Laxmanbhai J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239

← 1 2 3 4 5 →